This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
The EURIPID collaboration is currently funded by an annual contribution fee of the participants and – for defined tasks and deliverables – a grant of the EU.
This website is part of the project ’826652 Euripid’ which is co-funded by the European Union’s Health Programme (2014-2020).
The content of this website represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency (CHAFEA) or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information it contains.
What is the future of the EURIPID collaboration?
/in News /by Bettina HeindlOn 19 October 2023 the EURIPID collaboration held its annual Meeting of the Board of Participants (BoP). EURIPID members from 20 countries gathered at the premises of the Polish Agency for Health Technology Assessment and Tariff System (Agencja Oceny Technologii Medycznych i Taryfikacji, AOTMiT) in Warsaw. The meeting was facilitated by Momir Radulović, the Director […]
Chairs of WHO/Europe Access to Novel Medicines Platform (NMP) have been anounced
/in News /by Bettina HeindlAt the 72nd session of the WHO Regional Committee for Europe in September 2022 it was agreed to establish a formal stakeholder collaboration platform – the WHO/Europe Access to Novel Medicines Platform (NMP). The aim of the platform is to identify concrete actions, including pilot proposals, to improve affordable and equitable patient access to effective, […]
Croatias re-entry into EURIPID
/in News /by Bettina HeindlEURIPID is proud to announce Croatias re-entry into EURIPID. After careful negotations and fullfilling the necessary reqirements, Croatia has once again become a full-member of EURPID. Joining EURIPID brings numerous benefits. EURIPID supports countries by sharing pricing information on a wide range of pharmaceuticals. It helps policymakers to make informed decisions, monitor price developments and […]